...
首页> 外文期刊>European respiratory review >Airway granulation response to lung-implantable medical devices: a concise overview
【24h】

Airway granulation response to lung-implantable medical devices: a concise overview

机译:气道造粒对肺植入医疗设备的反应:简明概述

获取原文
           

摘要

Increasing numbers of endoscopically implantable devices are implanted in the airways, such as airway stents, one-way valves and coils, to treat both malignant and benign diseases. They significantly improve patient outcomes, but their long-term effectiveness and sustainability is hampered by the reaction of the formation of granulation tissue. Factors including procedural-related tissue injury; micro-organism presence; device-related factors, such as the material, design and sizing in relation to the airway; and patient-related factors, including genetic susceptibility, comorbidities and medication use, might all effect the severity of the tissue response and the subsequent degree of granulation tissue formation. However, research into the underlying mechanism and risk factors is scarce and therefore our knowledge is limited. Joint efforts from the scientific community, both pre-clinical and clinical, are needed to gain a deeper understanding and eventually improve the long-term treatment effectiveness of lung-implantable devices.
机译:越来越多的内窥镜植入装置被植入气道,例如气道支架,单向阀和线圈,以治疗恶性和良性疾病。它们显着改善了患者的结果,但它们的长期有效性和可持续性因粒状组织的形成反应而受到阻碍。包括程序相关的组织损伤的因素;微生物存在;设备相关因素,如材料,设计和尺寸与气道有关;患者相关的因素,包括遗传易感性,组织和药物使用,可能都会影响组织反应的严重程度和随后的造粒组织形成。然而,研究潜在机制和风险因素是稀缺的,因此我们的知识有限。需要从科学界,临床临床和临床的联合努力,以获得更深层次的理解,最终提高肺部植入装置的长期治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号